Rubrica iconografica
Dermatologia neonatale
STEFANO NOBILE, PATRIZIA OSIMANI, ANTONIO ZOPPI,* FERNANDO MARIA DE BENEDICTIS
Dipartimento di Pediatria, Azienda Ospedaliero-Universitaria “Ospedali Riuniti”, Ancona
*UO di Pediatria, Ospedale di Osimo
Febbraio 2008 - pagg. 117 -118
Classificazione MeSH
Bibliografia
1. Walker Metry D, Hebert AA. Benign cutaneous
vascular tumors of infancy. Arch Dermatol
2000;136:905-14.
2. Gottschling S, Schneider G, Meyer S, Reinhard H, Dill-Mueller D, Graf N. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer 2006;46:239-42.
3. Drolet B, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341: 173-81. 4 Lopriore E, Markhorst DG. Diffuse neonatal hemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr 1999; 88:93-7.
5. Fost NC, Esterly NB. Successful treatment of juvenile hemangiomas with prednisone. J Pediatr 1969;72:351-7.
6. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140:963-9.
7. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
8. Ozsoylu S. Megadose methylprednisolone for diffuse infantile haemangiomatosis. Eur J Pediatr 1992;15:389.
9. Uysal KM, Olgun N, Erbay A, Sarialioglu F. High-dose oral methylprednisolone therapy in childhood hemangiomas. Pediatr Hematol Oncol 2001;18:335-41.
10. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosterois for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007;6: 1239-47.
11. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-[alpha]-2b. J Pediatr Hematol Oncol 1997;19:237-44.
12. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1996;132:527-30.
13. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129:346-54.
14. Hurvitz SA, Hurvitz CH, Sloninsky L, Sanford MC. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000;22:527-32.
15. Payarols JP, Masferrer JP, Bellvert CG. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995; 333:69.
16. Wanankul S, Voramethkul W, Nuchprayoon I, Seksarn P. Diffuse neonatal hemangiomatosis: report of 5 cases. J Med Assoc Thai 2006;89:1297-303.
2. Gottschling S, Schneider G, Meyer S, Reinhard H, Dill-Mueller D, Graf N. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer 2006;46:239-42.
3. Drolet B, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341: 173-81. 4 Lopriore E, Markhorst DG. Diffuse neonatal hemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr 1999; 88:93-7.
5. Fost NC, Esterly NB. Successful treatment of juvenile hemangiomas with prednisone. J Pediatr 1969;72:351-7.
6. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140:963-9.
7. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
8. Ozsoylu S. Megadose methylprednisolone for diffuse infantile haemangiomatosis. Eur J Pediatr 1992;15:389.
9. Uysal KM, Olgun N, Erbay A, Sarialioglu F. High-dose oral methylprednisolone therapy in childhood hemangiomas. Pediatr Hematol Oncol 2001;18:335-41.
10. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosterois for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007;6: 1239-47.
11. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-[alpha]-2b. J Pediatr Hematol Oncol 1997;19:237-44.
12. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1996;132:527-30.
13. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129:346-54.
14. Hurvitz SA, Hurvitz CH, Sloninsky L, Sanford MC. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000;22:527-32.
15. Payarols JP, Masferrer JP, Bellvert CG. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995; 333:69.
16. Wanankul S, Voramethkul W, Nuchprayoon I, Seksarn P. Diffuse neonatal hemangiomatosis: report of 5 cases. J Med Assoc Thai 2006;89:1297-303.
Corrispondenza: debenedictis@ao-salesi.marche